FDA.reportPublic FDA data

Xphozah 30 MG Oral Tablet

RxCUI
2669454
RxNorm name
Xphozah 30 MG Oral Tablet
Display name
Xphozah 30 MG Oral Tablet
Full name
Xphozah 30 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:20

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
XPHOZAH 10 mgTENAPANORArdelyx, Inc.c57e279c-0f1b-4238-81b7-4e0dc0cc60c52025-06-27Warnings, Adverse reactionsExact identifier
rxcui: 2669454

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c57e279c-0f1b-4238-81b7-4e0dc0cc60c5XPHOZAH 30 MG Oral Tablet [PSN] · tenapanor 30 MG Oral Tablet [Xphozah] [SBD] · Xphozah 30 MG (as tenapanor hydrochloride 31.9 MG) Oral Tablet [SY] · Xphozah 30 MG Oral Tablet [SY]417These highlights do not include all the information needed to use XPHOZAH ® safely and effectively. See full prescribing information for XPHOZAH. XPHOZAH (tenapanor) tablets, for oral use Initial U.S. Approval: 201920250627